
CNS Brainstorm Episode 48 "Pediatric NF1 Therapeutics" with guest Bonnie Kaur, MD
Child Neurology Society's Brainstorm
00:00
Selumetinib clinical trial results
Bonnie Kaur recounts selumetinib's SPRINT trials showing 72% partial response and improvements in pain and quality of life.
Play episode from 05:40
Transcript


